EYSINS, Switzerland, Feb. 10, 2025 /PRNewswire/ — AliveDx announces it has submitted 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the MosaiQ AiPlex ® Celiac Disease ...
MiRNA microarray kits and reagents market is experiencing robust growth driven by rising demand for precision diagnostics, biomarker discovery, and translational research. Expansion of oncology ...
BILLERICA, Mass.--(BUSINESS WIRE)--Aushon BioSystems, Inc., a leading provider of advanced microarray instrumentation and laboratory services for biomarker discovery, development and analysis ...
Kit will aid investigation of developmental delay and mental retardation. Canterbury Health Laboratories has implemented the NimbleGen CGX Cytogenetics Microarray Solution. The kit includes arrays, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results